Boditech Med Inc. (KOSDAQ:206640)
South Korea · Delayed Price · Currency is KRW 11,570
+330 (2.94%)
Aug 11, 2026, 3:17 PM KST
Boditech Med Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 165,840 | 162,093 | 138,160 | 134,219 | 118,077 | 157,708 |
Revenue Growth | 15.04% | 17.32% | 2.94% | 13.67% | -25.13% | 9.42% |
Gross Profit Gross Profit Growth | 96,453 | 95,531 | 81,294 | 80,495 | 70,634 | 98,192 |
Operating Income Operating Income Growth | 27,674 | 28,940 | 26,129 | 28,257 | 24,671 | 51,936 |
Net Income Net Income Growth | 25,990 | 23,653 | 27,260 | 25,947 | 24,152 | 44,367 |
Earnings Per Share EPS Growth | 1200.55 | 1091.42 | 1242.00 | 1181.00 | 1079.94 | 1936.26 |
EPS Growth | -5.61% | -12.12% | 5.17% | 9.36% | -44.23% | -2.01% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 56,253 | 37,723 | 61,715 | 76,198 | 60,459 | 68,469 |
Total Debt Total Debt Growth | 13,737 | 17,749 | 11,087 | 10,568 | 8,895 | 6,866 |
Net Cash (Debt) Net Cash Growth | 42,516 | 19,975 | 50,629 | 65,630 | 51,564 | 61,603 |
Net Cash Growth | -18.50% | -60.55% | -22.86% | 27.28% | -16.30% | 30.40% |
Net Cash Per Share Net Cash Per Share Growth | 1963.96 | 921.69 | 2306.67 | 2987.51 | 2305.67 | 2688.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 20,631 | 22,081 | 24,879 | 34,300 | 23,068 | 49,927 |
Capital Expenditures CapEx Growth | -36,072 | -33,013 | -11,427 | -4,605 | -15,260 | -18,230 |
Free Cash Flow Free Cash Flow Growth | -15,441 | -10,932 | 13,452 | 29,695 | 7,808 | 31,697 |
Free Cash Flow Growth | - | - | -54.70% | 280.32% | -75.37% | -21.86% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.16% | 58.94% | 58.84% | 59.97% | 59.82% | 62.26% |
Operating Margin | 16.69% | 17.85% | 18.91% | 21.05% | 20.89% | 32.93% |
Pretax Margin | 18.72% | 17.14% | 23.45% | 23.52% | 22.84% | 35.53% |
Profit Margin | 15.67% | 14.59% | 19.73% | 19.33% | 20.45% | 28.13% |
FCF Margin | -9.31% | -6.74% | 9.74% | 22.12% | 6.61% | 20.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 150.000 | - | - | 200.000 | 150.000 | 200.000 |
Dividend Per Share Growth | 0% | - | - | 33.33% | -25.00% | 0% |
Dividend Yield | 1.36% | - | - | 1.01% | 1.52% | 1.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.36 | 12.08 | 13.53 | 17.36 | 9.32 | 8.62 |
Forward PE | - | 9.30 | 10.86 | 15.59 | 23.45 | 23.45 |
P/FCF Ratio | - | - | 27.41 | 15.17 | 28.84 | 12.06 |
PS Ratio | 1.38 | 1.76 | 2.67 | 3.36 | 1.91 | 2.42 |